Progyny
Update in progressPGNY (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryHealthcare Plans
Progyny, Inc. is a benefits management company in the United States specializing in fertility, family building, and women’s health benefits. It offers a differentiated fertility plan with a smart cycle treatment bundle, concierge-style member support, and access to a selective network of fertility specialists. Progyny Rx provides medication access and care management. It also supports pregnancy/postpartum, menopause, leave navigation, wellbeing, and reimbursement programs for adoption, surrogacy, doula, and travel. Formerly Auxogyn, Inc., it renamed Progyny in 2015; founded in 2008 and headquartered in New York, NY.
Company score
- Sentiment
- 0.21
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.27
- Governance
- -0.03
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.07
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.14
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!